Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
OncoMyx Therapeutics

OncoMyx Therapeutics

Oncolytic Immunotherapy

OverviewStructured DataIssuesContributorsActivity
Is a
Organization
Organization
Company
Company
CIK Number
1,779,436
Company Operating Status
Active
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...ics-b6ca
Founded Date
2018
Full Address
850 N. 5th St., Ste. 402 PHOENIX, AZ 85004
Industry
Cancer immunotherapy
Cancer immunotherapy
Biomedical engineering
Biomedical engineering
Oncolytic virus
Oncolytic virus
Cancer
Cancer
Oncology
Oncology
Internal medicine
Internal medicine
Healthcare
Healthcare
Medicine
Medicine
Immunotherapy
Immunotherapy
Engineering
Engineering
Investors
B Capital Group
B Capital Group
Lumira Ventures
Lumira Ventures
City Hill Ventures
City Hill Ventures
Korea Investment Partners
Korea Investment Partners
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund
Xeraya Capital
Xeraya Capital
Delos Capital
Delos Capital
LYZZ Capital
LYZZ Capital
Latest Funding Round Date
December 8, 2021
Latest Funding Round Amount (USD)
50,000,000
Latest Funding Type
Series B Round
Series B Round
LinkedIn URL
@company/oncomyx
Location
Phoenix, Arizona
Phoenix, Arizona
United States
United States
Pitchbook URL
pitchbook.com/profiles...267911-65
Total Funding Amount (USD)
75,000,000
Twitter URL
@oncomyx
Official Website
oncomyx.com

Find more companies like OncoMyx Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo